Showing results (11-20 of 1,026) with videos related to
Sort By:
Pageof 103
Praxis|March 17, 2016
[Gliomas – What I Have to Know in ten Questions]Wiebke Gulden-Sala, Patrick Roth, Michelle Brown, et al.The Lancet. Oncology|July 31, 2013
Molecular neuro-oncology in clinical practice: a new horizonMichael Weller, Stefan M Pfister, Wolfgang Wick, et al.Neuro-Oncology|February 18, 2009
Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitroGabriele D Maurer, Isabel Tritschler, Barbara Adams, et al.Future Oncology (London, England)|March 23, 2011
Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignanciesDavid A Reardon, Bart Neyns, Michael Weller, et al.Targeted Oncology|September 8, 2010
Targeting integrins in malignant gliomaGhazaleh Tabatabai, Michael Weller, Burt Nabors, et al.International Journal of Cancer|April 14, 2019
Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysisCorinna Seliger, Els Genbrugge, Thierry Gorlia, et al.Annals of Neurology|July 26, 2011
Current concepts and management of glioblastomaMatthias Preusser, Sandrine de Ribaupierre, Adelheid Wöhrer, et al.International Journal of Cancer|November 8, 2022
Association of antidepressant drug use with outcome of patients with glioblastomaCorinna Seliger, Felix Boakye Oppong, Florence Lefranc, et al.Journal of Neuro-Oncology|April 17, 2014
Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patientsThomas Hundsberger, Michaela Tonder, Andreas Hottinger, et al.Acta Neuropathologica|September 24, 2010
Molecular diagnostics of gliomas: the clinical perspectiveGhazaleh Tabatabai, Roger Stupp, Martin J van den Bent, et al.Pageof 103